Equities

Camlin Fine Sciences Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CAMLINFINE:NSI

Camlin Fine Sciences Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)144.14
  • Today's Change-3.66 / -2.48%
  • Shares traded396.30k
  • 1 Year change+0.94%
  • Beta1.2893
Data delayed at least 15 minutes, as of Mar 02 2026 10:21 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Camlin Fine Sciences Limited is an India-based company, which is engaged in the research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company’s products are categorized into shelf-life solutions, performance chemicals, aroma ingredients, and health and wellness. Its products include catechol, tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), Ascorbyl Palmitate (ASP), 4-Tertiary Butyl Catechol, Xtendra, Guaiacol, Para DiMethoxy Benzene, NaSure, Hydroquinone, and Veratrole. Its aroma ingredients mainly include Vanillin, Ethyl Vanillin, and Natural Vanillin. The Company’s products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances, and health care. Its brands include Ezential, Nasure, adorr, Dinamics, Xtendra, and Biosis.

  • Revenue in INR (TTM)17.55bn
  • Net income in INR1.71bn
  • Incorporated1993
  • Employees661.00
  • Location
    Camlin Fine Sciences LtdPlot No F/11 & F/12,Wicel CompoundOpp Seepz Main Gate, Midc Central RoadMUMBAI 400098IndiaIND
  • Phone+91 2 267001000
  • Fax+91 2 228324404
  • Websitehttps://www.camlinfs.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nocil Ltd13.12bn594.20m23.10bn737.0038.85--20.251.763.563.5678.57--------17,806,110.00--7.16--8.0141.7731.454.539.35--41.73--33.36-3.6010.48-22.66-4.67-7.36--
Bharat Rasayan Ltd12.40bn1.33bn24.34bn651.0018.34--15.271.9679.8479.84746.29--------19,053,040.00--13.11--16.3234.1127.0910.7011.99--36.61--0.446612.29-0.701947.54-2.22-9.390.00
Sirca Paints India Ltd4.59bn614.45m24.93bn659.0039.59--35.105.4311.0911.0982.95--------6,969,625.00--12.64--14.7946.4640.7413.3814.72--21.27----19.9822.59-4.6214.2936.45--
Bhagiradha Chemicals and Industries Ltd5.00bn132.15m25.92bn546.00197.95--87.865.181.011.0140.19--------9,166,097.00--6.15--8.3935.6026.132.646.48--2.30--7.258.0512.39-23.9516.3245.39--
Kiri Industries Ltd7.94bn49.67bn26.10bn811.000.5541--0.53893.29784.73784.73142.08--------9,792,472.00--7.41--8.6025.1218.93603.9324.32--------4.43-10.7359.26-6.7529.18--
Polyplex Corp Ltd69.55bn302.58m26.37bn935.0087.12--7.760.37919.649.642,215.30--------74,381,870.00--8.22--14.9431.1231.61-0.0778.91--0.6342--42.249.178.94453.00-5.801.26-4.51
Fineotex Chemical Ltd5.78bn971.13m26.70bn210.0026.04--23.764.620.88070.88075.22--------27,536,990.00--20.17--24.2935.8036.5617.5319.09--89.09--6.19-6.2622.12-9.6852.6061.0074.11
Rossari Biotech Ltd22.91bn1.38bn26.86bn535.0019.52--12.701.1724.8424.84413.31--------42,823,640.00--9.29--12.6031.2729.566.017.12--8.71--2.4613.6428.234.3515.8915.85--
Jubilant Agri and Consumer Products Ltd18.04bn1.24bn27.16bn1.40k22.34--19.241.5180.2480.241,161.64--------12,850,290.00--------41.73--6.87----24.29----24.56--187.85------
Ddev Plastiks Industries Ltd29.19bn1.99bn27.34bn400.0013.74--12.630.936819.2319.23281.97--------72,975,060.00--------17.21--6.82----10.28----7.08--2.11------
Tatva Chintan Pharma Chem Ltd4.80bn327.63m27.38bn679.0083.52--40.795.7114.0114.01205.18--------7,063,005.00--7.43--9.6052.8742.226.8311.88--21.79--6.91-2.747.77-81.18-31.479.63--
Camlin Fine Sciences Ltd17.55bn1.71bn27.69bn661.0014.00--12.011.5810.29-3.2595.63--------26,547,460.00--3.00--4.8547.1538.429.663.62--1.33--0.0014.629.705.2217.70-20.56--
Premier Explosives Ltd3.73bn429.74m27.72bn838.0064.47--50.607.438.008.0069.45--------4,453,657.00--3.19--5.1844.9647.7811.524.69--9.72--15.1153.6420.471.19---14.55--
Krishana Phoschem Ltd21.35bn1.30bn29.19bn267.0022.46--17.881.3721.0221.02345.46--------79,977,190.00--7.95--11.8230.1630.156.086.51--6.99--5.1947.0152.82113.9844.4298.7814.87
NACL Industries Ltd14.25bn-445.70m29.95bn1.35k------2.10-2.06-2.0665.81--------10,578,620.00--0.9308--2.1730.1020.61-3.130.8582---0.2909--44.83-30.604.00-56.44---13.76--
Data as of Mar 02 2026. Currency figures normalised to Camlin Fine Sciences Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

7.00%Per cent of shares held by top holders
HolderShares% Held
ICICI Prudential Asset Management Co. Ltd. (Invt Mgmt)as of 31 Jan 20267.74m4.03%
Franklin Templeton Asset Management (India) Pvt Ltd.as of 30 Jan 20264.72m2.46%
Dimensional Fund Advisors LPas of 05 Feb 2026500.47k0.26%
SSgA Funds Management, Inc.as of 05 Feb 2026210.43k0.11%
Dimensional Fund Advisors Ltd.as of 30 Nov 2025132.23k0.07%
American Century Investment Management, Inc.as of 05 Feb 2026127.14k0.07%
DFA Australia Ltd.as of 31 Jan 202610.38k0.01%
Motilal Oswal Asset Management Co. Ltd.as of 31 Jan 2026250.000.00%
Lacuna Verm�gen GmbHas of 31 Dec 20240.000.00%
Eastspring Investments (Singapore) Ltd.as of 31 Aug 20230.000.00%
More ▼
Data from 31 Dec 2024 - 15 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.